Q2 FY27 PAT Rises 64% QoQ to ₹15.99 Cr; Revenue Up 43% to ₹106.34 Cr
Veegaland Developers reported strong Q2 FY27 results, with revenue from operations growing 43% QoQ to ₹106.34 cr (₹10,634.29 lakhs) and 28.7% YoY from ₹82.66 cr. Standalone net profit surged 64% QoQ to ₹15.99 cr (₹1,598.80 lakhs) compared to ₹9.72 cr in Q1 FY27, while basic EPS rose to ₹4.46. Following its September 18, 2026 listing which raised ₹210.00 cr (gross), net IPO proceeds of ₹188.68 cr remain entirely unutilised as of September 30, 2026. Total cash and bank balances stood elevated at ₹184.60 cr, strengthening the balance sheet for upcoming project execution.
high confidence
What changedVeegaland announced its maiden quarterly financial results post-listing, showing sharp sequential growth in top-line and net profit alongside an expanded equity base of ₹48.75 cr.
Why it mattersThe operational scale-up and fresh IPO liquidity of ₹188.68 cr provide growth capital for ongoing and upcoming real estate projects, with zero short-term capital constraints.
📅 Short termStrong quarterly performance and robust cash position are likely to be viewed favorably in the near term following the recent listing.
📈 Long termExecution capability across funded projects and timely deployment of land acquisition capital will dictate sustained margin and revenue visibility over the coming years.
⚠ Risk flags
Cyclicality and project execution delays typical of the real estate sector
👀 What to Watch
Track the deployment timeline of the ₹188.68 cr unutilised IPO proceeds across ongoing project development (₹119.83 cr) and land acquisitions (₹68.86 cr), along with future delivery milestones.
📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures,
short/long-term view and what to watch.
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
Nagreeka Exports Q2 PAT Rises 24% YoY to ₹1.35 Cr; Revenue Up 25.6% to ₹154.44 Cr
Nagreeka Exports reported a 25.6% YoY growth in revenue from operations to ₹154.44 crore for Q2 FY27 (ended September 30, 2026), compared to ₹123.00 crore in Q2 FY26. Net profit after tax rose 24.0% YoY to ₹1.35 crore from ₹1.09 crore. For H1 FY27, net profit stood at ₹2.39 crore on revenue of ₹328.26 crore. Operating cash flow for H1 turned negative at -₹11.00 crore due to working capital absorption, while long-term borrowings surged to ₹63.20 crore from ₹22.60 crore in March 2026.
high confidence
What changedNagreeka Exports declared its Q2 and H1 FY27 financial results showing revenue and net profit growth alongside higher debt and negative operating cash flow.
Why it mattersWhile top-line growth remains healthy at over 25%, margins remain thin (PAT margin under 1%) and an increase in long-term borrowings raises financial leverage on an already leveraged balance sheet.
📅 Short termMuted impact expected as steady top-line growth is counterbalanced by thin net margins (0.87%) and cash flow strain.
📈 Long termStructural turnaround hinges on scaling higher-margin home textile products and successfully commissioning CWIP to service elevated debt obligations.
⚠ Risk flags
Negative H1 operating cash flow of -₹11.00 cr due to inventory and receivable build-up
Sharp increase in long-term borrowings from ₹22.60 cr to ₹63.20 cr over six months
Very thin net profit margins (<1%) leaving minimal buffer against input cost fluctuations
👀 What to Watch
Track whether working capital normalizes in subsequent quarters and monitor the completion timeline of the expanded capital work-in-progress (₹28.82 cr).
India Ratings Upgrades Manorama Industries' Bank Loan Facilities to IND A+/Positive/IND A1+
Manorama Industries Limited has received a credit rating upgrade from India Ratings and Research for its bank loan facilities totaling Rs 496.77 crore (INR 4,967.70 million). The long-term and short-term ratings have been upgraded to IND A+/Positive and IND A1+, respectively. This upgrade reflects strengthening operational and financial performance, backed by TTM revenue of Rs 1,482 crore and a low D/E ratio of 0.51. The rated facilities represent approximately 71.5% of the company's net worth of Rs 695 crore.
high confidence
What changedIndia Ratings upgraded Manorama Industries' bank loan facilities to IND A+/Positive/IND A1+ from previous ratings.
Why it mattersThe upgrade validates the company's balance sheet strength, lower leverage profile, and may help reduce debt servicing costs across its Rs 496.77 crore bank facilities.
Bank loan facilities size: INR 4,967.70 millionUpgraded Rating: IND A+/Positive/IND A1+Facility size vs TTM revenue: ~33.5%Facility size vs Net Worth: ~71.5%
📅 Short termPositive sentiment driver in the immediate term reflecting credit profile enhancement.
📈 Long termEnhances financial flexibility and reduces interest cost pressures as the company scales capacity towards its target utilization.
👀 What to Watch
Monitor upcoming quarterly results and management commentary on borrowing costs, as rating upgrades typically lower working capital interest spreads.
CARE Reaffirms HBL Engineering's Long-Term Rating at CARE AA-; Stable for ₹995 Cr Facilities
CARE Ratings Limited has reviewed and updated credit ratings for HBL Engineering Limited across ₹995 crore of total bank facilities. Long-term bank facilities of ₹149 crore and short-term facilities of ₹95 crore were reaffirmed at 'CARE AA-; Stable' and 'CARE A1+', respectively. For the ₹751 crore long-term/short-term facilities, CARE reaffirmed 'CARE A1+' and assigned a long-term rating of 'CARE AA-; Stable'. With company debt at just ₹48 crore and D/E of 0.02, these rated limits mainly support operational non-fund needs like bank guarantees and letters of credit.
high confidence
What changedCARE Ratings reaffirmed existing long-term and short-term ratings and formally assigned a 'CARE AA-; Stable' long-term rating alongside 'CARE A1+' for ₹751 crore in non-fund based facilities.
Why it mattersConfirms steady creditworthiness and continued lender support for critical non-fund bank guarantee lines needed for railway and defense execution.
Total rated bank facilities: Rs.995.00 croreNon-fund based facilities: Rs.751.00 croreFund-based long-term facilities: Rs.149.00 croreFund-based short-term facilities: Rs.95.00 crore
📅 Short termNeutral impact as the rating reaffirmation and assignment reflect an unchanged stable credit risk profile.
📈 Long termDemonstrates strong financial health and access to low-cost banking facilities, backed by the company's low leverage (D/E of 0.02).
⚠ Risk flags
Elongated working capital cycle and reliance on non-fund facilities for large infrastructure execution
👀 What to Watch
Track working capital utilization and non-fund guarantee execution as the company delivers on railway (Kavach) and industrial battery contracts.
Zydus Lifesciences Q2 FY27 Earnings Call: Revenue Up 29% YoY to ₹79.1B, EBITDA Margins at 24%
Zydus Lifesciences submitted the transcript of its Q2 FY27 post-results earnings call held on November 4, 2026. Consolidated revenue grew 29% YoY to ₹79.1 billion, with EBITDA reaching ₹18.9 billion and net profit at ₹9.3 billion. Operating profitability maintained a 24% EBITDA margin despite continued upfront investments in Saroglitazar US launch preparations. US revenue expanded 21% YoY to ₹33.1 billion with specialty products contributing 16% of US sales, while the India branded formulations business grew 19% YoY.
high confidence
What changedSubmission of the detailed Q2 FY27 earnings call transcript clarifying segment performance, product pipelines, and USFDA inspection statuses.
Why it mattersDemonstrates strong operational execution with base US business growth outperforming Mirabegron price erosion, alongside strategic expansion into high-margin specialty and biosimilars portfolios.
📅 Short termEarnings transcript details provide clarity on underlying base business resilience, which management expects to sustain for the next 2 quarters.
📈 Long termPivoting towards specialty products, biosimilars (Pembrolizumab BLA accepted), and NCE launches like Saroglitazar positions the company for higher margin durability beyond standard US generics.
⚠ Risk flags
Regulatory compliance risks following USFDA inspection observations at SEZ-II (1 observation) and Moraiya (5 observations).
Sustained promotional expenses for the Saroglitazar US launch which may continue to pressure EBITDA margins.
👀 What to Watch
Track the regulatory resolution of the 5 USFDA observations at Moraiya and 1 at SEZ-II Ahmedabad, as well as the commercialization progress of Saroglitazar in the US.
CL Educate H1 FY27 Call: EBITDA Jumps 14% to ₹57 Cr Despite 4% Drop in Revenue
CL Educate filed its Q2/H1 FY27 earnings call transcript, highlighting an EBITDA increase from ₹50 Cr to ₹57 Cr with EBITDA margins expanding 300 bps to 18.6%, despite consolidated revenue dipping 4% to ₹305 Cr. Performance was bolstered by ₹12.5 Cr in overhead cost savings in H1, with management targeting ₹20-22 Cr in annual savings. Multi-year contract wins at DEXIT Global reached ₹172 Cr (equal to ~32.5% of TTM revenue of ₹530 Cr), deliverable over 2-3 years. Additionally, NCLT approved the redemption of ₹203 Cr in preference shares in July, trimming the balance sheet.
high confidence
What changedSubmission of the detailed transcript for the Q2/H1 FY27 earnings call held on November 04, 2026.
Why it mattersManagement articulated ongoing margin expansion via aggressive cost rationalization and highlighted stable multi-year revenue visibility through ₹172 Cr in DEXIT contracts.
📅 Short termProvides clarity on operating profitability improvements and debt repayment run-rate following previous quarterly losses.
📈 Long termMargin sustainability will depend on reviving top-line growth in test prep and delivering steady exam volumes in DEXIT while deleveraging the ₹174 Cr acquisition debt.
⚠ Risk flags
Revenue decline of 13% in the core EdTech segment due to broader test prep industry headwinds
High long-term debt burden of ₹174 Cr plus ₹55-60 Cr short-term borrowings suppressing net earnings
👀 What to Watch
Track H2 FY27 revenue execution against the ₹172 Cr order book in DEXIT, alongside progress in reducing acquisition debt from annual cash flows.
Mr. Sukesh Kumar Sharma, Executive Director (Whole-time Director and KMP), has resigned from K&R Rail Engineering effective November 6, 2026. The director cited 'unexplainable reasons' in his resignation letter after serving around five years with the company. He held nil shares in the firm. This exit comes amid severe financial stress, with TTM revenue dropping to Rs 62 Cr and TTM PAT at Rs -20 Cr.
high confidence
What changedMr. Sukesh Kumar Sharma stepped down as Executive Director, Whole-time Director, and KMP effective November 6, 2026.
Why it mattersThe sudden exit of a key managerial personnel citing ambiguous 'unexplainable reasons' raises corporate governance flags, particularly as the business is experiencing shrinking revenues and operational losses.
Effective date of cessation: 06.11.2026Tenure of director: about 5 yearsResigning director shareholding: NilTTM Revenue: Rs 62 Cr
📅 Short termNegative sentiment around management stability may weigh on the stock, which has already declined 44.3% over the past 12 months.
📈 Long termUnless leadership stabilizes and operational recovery takes place, turnover in top executive roles adds uncertainty to operational turnaround efforts.
⚠ Risk flags
Ambiguous resignation reason ('unexplainable reasons') from a key managerial personnel
Company is currently loss-making with an operating profit margin of -31.9%
👀 What to Watch
Track subsequent board appointments to fill the Executive Director/KMP vacancy and monitor governance disclosures in upcoming quarterly filings.
Zydus Wellness Q2 FY27 Call: Net Sales Up 74.6% YoY to ₹1,122.7 Cr, EBITDA Jumps 271.7%
Zydus Wellness submitted its Q2 FY27 earnings call transcript, highlighting consolidated net sales of ₹1,122.7 crore (up 74.6% YoY) and H1 FY27 net sales of ₹2,552.6 crore (up 70.1% YoY). Consolidated EBITDA for the quarter rose 271.7% YoY to ₹85.5 crore, supported by gross margin expansion and consolidation of Comfort Click. The domestic portfolio grew 29.2% YoY, led by a 123.5% rebound in seasonal brands and 37.5% growth in skin and hair care. Management highlighted moderating like-to-like growth in Comfort Click to 12.4% during Q2 (18.6% in H1) due to web migration and higher competition, while Complan maintained its positive momentum for three consecutive quarters.
high confidence
What changedSubmission of the verbatim transcript for the Q2 FY27 earnings conference call held on November 3, 2026.
Why it mattersProvides detailed qualitative and segment-level context on the integration and margin dynamics of Comfort Click, as well as the turnaround initiatives in Complan.
Q2 FY27 Net Sales: INR 11,227 millionQ2 Net Sales YoY Growth: 74.6%Q2 FY27 EBITDA: INR 855 millionQ2 EBITDA YoY Growth: 271.7%H1 FY27 Net Sales: INR 25,526 millionH1 FY27 EBITDA: INR 3,272 million
📅 Short termTranscript reveals operational details; post-earnings price reactions have already factored in Q2 headline numbers, but commentary clarifies Comfort Click's competitive landscape.
📈 Long termSuccess depends on diversifying away from summer seasonality (Glucon-D/Nycil) through international nutraceuticals (Comfort Click) and maintaining market share in health food drinks (Complan).
⚠ Risk flags
Competitive intensity increasing in Comfort Click's key international VMS markets
High structural seasonality with summer products
👀 What to Watch
Track whether Comfort Click's like-to-like growth re-accelerates beyond 12.4% following marketing ramp-ups, and monitor sustainability of Complan's double-digit trajectory over coming quarters.
Capacit'e Reports Q2 Revenue of ₹771 Cr, Order Book Reaches ₹13,013 Cr
Capacit'e Infraprojects released its Q2 FY27 earnings call transcript, highlighting a record quarterly revenue of ₹771 crore, up 19% YoY. EBITDA for the quarter stood at ₹119 crore with a 15.5% margin, while PAT declined slightly to ₹48 crore from ₹51 crore in Q2 FY26. The total order book reached ₹13,013 crore (4.89x TTM revenue), supported by ₹2,487 crore in new order inflows during FY27 so far. Working capital cycle improved by 11 days quarter-on-quarter, though net contract assets and receivables remain elevated at approximately ₹2,400 crore.
high confidence
What changedFiling of the Q2 FY27 earnings conference call transcript detailing financial performance, operational updates, and debtor recoveries.
Why it mattersDemonstrates strong top-line scale-up and solid revenue visibility (order book is ~4.89x TTM revenue), though working capital intensity and margin stabilization remain key focal areas.
Q2 FY27 Revenue: ₹771 crOrder Book: ₹13,013 crOrder Book vs TTM Revenue: ~489%FY27 Inflows to date: ₹2,487 crQ2 FY27 EBITDA margin: 15.5%Net Receivables + Contract Assets: ₹2,400 cr
📅 Short termEarnings details and commentary are already largely absorbed post-results; immediate attention will center on upcoming project win announcements like CIDCO.
📈 Long termThe robust order book of ₹13,013 crore provides multi-year revenue visibility, but sustained shareholder value depends on converting contract assets into cash flows and reducing leverage.
⚠ Risk flags
High working capital intensity with ~₹2,400 crore locked in net contract assets and trade receivables.
Slight YoY compression in net profit margin (6.1% vs previous year) due to elevated commodity input costs.
👀 What to Watch
Track the formal award of the CIDCO project expected within 10 days and monitor working capital cash conversion from the ₹2,400 crore receivables/contract assets pool.
NHC Foods Reports Q2 Revenue of ₹451.3 Cr; Acquires 99.98% of Sachmaas Foods for ₹1.8 Cr
NHC Foods reported consolidated revenue of ₹451.32 crore for Q2 FY27 (quarter ended Sep 30, 2026), up from ₹370.13 crore in Q1 FY27, with segment PBT reaching ₹23.36 crore. H1 FY27 total revenue stood at ₹821.46 crore, nearly matching its entire TTM revenue base of ₹860 crore, led by a surge in international trading. Additionally, the Board approved the acquisition of a 99.98% stake in partnership firm M/s Sachmaas Foods for ₹1.80 crore to expand chickpea and peanut processing. The board also appointed Mr. Jayesh Dhirajlal Shah as an Additional Executive Director.
high confidence
What changedNHC Foods announced its Q2/H1 FY27 financial results, acquired 99.98% of Sachmaas Foods for ₹1.80 crore, and appointed Jayesh Dhirajlal Shah as Executive Director.
Why it mattersTop-line run-rate has accelerated sharply via international trading segments, while the acquisition adds manufacturing and packaging capabilities in pulses and peanuts.
📅 Short termThe strong sequential revenue growth and substantial profit expansion are likely to be viewed favourably by the market in the near term.
📈 Long termLong-term viability will depend on stabilizing trading margins, integrating the acquired food processing business, and converting high top-line growth into sustainable operating cash flows.
⚠ Risk flags
0.0% promoter holding context.
Substantial increase in trade receivables (₹60.57 cr absorbed in H1 FY27).
Significant rise in non-current borrowings by ₹202.49 crore during the half-year.
👀 What to Watch
Track shareholder approval via postal ballot for director appointment, and monitor working capital cycles as trade receivables and short-term debt have expanded significantly.
Kuber Udyog: RBI Cancels NBFC CoR; Issues 11.58 Cr Equity Shares & 26% Open Offer at ₹23.35
Kuber Udyog received RBI approval on November 06, 2026, cancelling its Certificate of Registration as an NBFC pursuant to a voluntary application. The company also confirmed board approval for preferential allotments totaling 11.58 crore equity shares at ₹23.10 each, including 7.62 crore shares issued for consideration other than cash to acquire 100% of Golden Ikon Fleet Management Private Limited. Concurrently, Acquirers Manav Bahri, Dinesh Popli, and Ajay Dutta have launched an open offer to acquire up to 3,19,71,680 equity shares (26% of expanded voting capital) at ₹23.35 per share.
high confidence
What changedRBI approved the cancellation of Kuber Udyog's NBFC license, and the board approved massive preferential share and warrant allotments for the Golden Ikon acquisition and cash, triggering an open offer at ₹23.35.
Why it mattersThe company is completely pivoting away from NBFC operations toward fleet management, accompanied by massive share capital expansion and management/promoter restructuring.
Open offer size: 3,19,71,680 shares (26.00%)Open offer price: ₹23.35 per shareShares issued for Golden Ikon acquisition: 7,62,85,000 sharesCash preferential shares issued: 3,95,50,000 sharesPreferential issue price: ₹23.10 per shareConvertible warrants issued: 37,00,000 warrants
📅 Short termThe open offer price of ₹23.35 is at a steep discount to the current market price of ₹47.7, which may limit retail tendering interest. The receipt of BSE listing approvals for the newly allotted shares will be a key near-term milestone.
📈 Long termThe complete operational transformation through the acquisition of Golden Ikon Fleet Management and abandonment of the NBFC license fundamentally changes the business model, risk profile, and future revenue drivers.
⚠ Risk flags
Extremely large equity dilution from the issuance of over 11.58 crore new shares.
Business transition risk following the surrender of the NBFC registration and pivot to fleet management.
Offer price of ₹23.35 sits significantly below the current trading price of ₹47.7.
👀 What to Watch
Track the open offer tendering schedule and BSE listing/trading approvals for the newly allotted shares. Monitor post-merger integration of Golden Ikon Fleet Management and subsequent business strategy following the exit from NBFC operations.
H1 FY27 Revenue Up 39% to ₹118.6 Cr; Approves New Indian Export Facility & R&D Center
Maximus International reported a 38.99% growth in H1 FY27 revenue to ₹118.64 crore, alongside Q2 FY27 revenue of ₹58.74 crore and net profit of ₹2.05 crore. Operating margins saw pressure from geopolitical supply chain tensions, with Q2 EBITDA margin at 7.77% and PAT margin at 3.46%. Concurrently, the Board approved setting up a domestic export-oriented manufacturing facility and R&D center in India to complement existing units in the UAE and Kenya. Specific capex figures, project capacity, and implementation timelines for the new facility were not disclosed.
high confidence
What changedThe company announced H1 FY27 financial results and the Board's approval to establish an export-oriented lubricant production facility and R&D center in India.
Why it mattersExpanding manufacturing to India beyond its current UAE and Kenya bases could improve supply chain security and export scale, though input cost volatility remains a headwind.
📅 Short termMarket reaction will likely weigh top-line expansion against raw material and logistics cost pressures impacting profitability margins.
📈 Long termEstablishing a domestic production base alongside existing overseas units in the UAE and Kenya may structurally support long-term export volumes and formulation capability.
⚠ Risk flags
Input cost volatility in base oils and distribution costs driven by Middle East geopolitical tensions
Lack of disclosed details on capex size, funding mode, or commissioning timeline for the new plant
👀 What to Watch
Track subsequent regulatory filings for capex outlay, location, funding structure, and targeted commissioning dates for the planned Indian manufacturing facility.
Hester Bio Q2 Transcript: Standalone PAT Up 131%, Gross Margin at 78%
Hester Biosciences released its earnings conference call transcript for Q2 and H1 FY27. Standalone revenue grew 28% in Q2, with PAT rising 131%, supported by strong gross margins of 78% and EBITDA margins of 35%. Consolidated revenue grew 38% in Q2, led by Poultry Healthcare rising 27% and Animal Healthcare rising 34%. Management confirmed consolidated debt stands at ₹102 crore with cash of ₹23 crore, translating to net debt of ~₹80 crore.
high confidence
What changedSubmission of the detailed earnings conference call transcript discussing Q2 and H1 FY27 operating performance and segment updates.
Why it mattersProvides insights into sustained operating margin expansion (EBITDA margin at 35%), Poultry Healthcare momentum, and debt levels (~₹80 crore net debt vs ₹407 crore net worth).
📅 Short termMarket sentiment should stay supported by high margin execution and robust 35% EBITDA margins, though the primary results were already reported earlier.
📈 Long termGrowth hinges on ramping up utilization at the newly capitalized BSL-3 facility, expanding H9N2 exports, and stabilizing Africa and Nepal operations.
⚠ Risk flags
Delays in Nepal PPR procurement scale
Dependency on government tenders leading to lumpiness in Animal Healthcare revenue
Regulatory tightening lengthening approval cycles for biologicals
👀 What to Watch
Track export registration timelines for the H9N2 poultry vaccine and monitor the operational turnaround in the Africa and Nepal units in upcoming quarters.
Shyam Metalics Q2 FY27 Concall: Revenue Up 33.4% to Rs 5,960 Cr; Outlines Vision 2031 Capex
Shyam Metalics released its Q2 FY27 earnings call transcript, reporting a 33.4% YoY revenue growth to Rs 5,960 crore supported by a 26% rise in sales volumes. Management outlined aggressive expansion under Vision 2031, targeting over 3 million tons of value-added steel capacity (1.6 MT HR mill, 0.8 MT specialty bar combo mill, and 0.6 MT stainless steel) with guided EBITDA exceeding Rs 10,000 per ton. Key strategic initiatives include a Rs 2,700 crore stainless steel expansion in Odisha targeted for commissioning by March 2029 and acquiring a 51% stake in Alom Solar (Phutamura coal block) with an estimated capex share of Rs 185 crore.
high confidence
What changedSubmission of the formal transcript of the Q2 FY27 investor and analyst conference call held on November 02, 2026.
Why it mattersProvides detailed management guidance on capex, project-level EBITDA targets (exceeding Rs 10,000/ton), and backward integration into captive coal that underpins the company's shift toward high-margin value-added products.
Q2 FY27 Revenue: Rs 5,960 croreYoY Revenue Growth: 33.4%Stainless Steel Expansion Capex: Rs 2,700 croreKharagpur Auto Steel Capex: Rs 900 crorePhutamura Coal Capex (Company Share): Rs 185 croreTarget EBITDA per ton on new projects: > Rs 10,000
📅 Short termTranscript provides operational clarity following the Q2 results; sentiment is supported by robust 26% volume growth and cost pass-through commentary.
📈 Long termVision 2031 projects (3+ MTPA added capacity in HR, SBQ, and stainless steel) combined with captive coal could structurally shift product mix toward value-added segments, driving substantial margin expansion if commissioned on schedule.
⚠ Risk flags
Execution and commissioning delays across large multi-year capex projects (Odisha plant slated for March 2029)
Cyclical steel pricing and exposure to raw material price volatility prior to captive coal commercialization
👀 What to Watch
Track execution milestones and commissioning timelines for the Kharagpur auto steel mill and Odisha stainless steel facility through FY29, alongside commercial coal production progress at Phutamura slated for July 2027.
SRPL Reports Q2 Loss of ₹15.25 Cr; Secured Assets Auctioned by Lender for ₹20.58 Cr
Shree Ram Proteins reported zero revenue from operations and a net loss of ₹15.25 crore for Q2 FY27 (quarter ended September 30, 2026), compared to a loss of ₹4.97 crore in Q2 FY26. Total income of ₹15.06 crore was driven entirely by a net gain on sale of assets following SARFAESI action by Union Bank of India, which auctioned plant, machinery, land, and buildings for ₹20.58 crore. The company took an exceptional inventory write-off of ₹11.18 crore and wrote off ₹24.26 crore of supplier advances during H1. The board re-appointed CMD Lalitkumar Vasoya for three years starting July 2027 and approved M/s H. Jamnadas & Co. as new statutory auditors.
high confidence
What changedLenders auctioned off the company's core production assets (plant, machinery, and land) under SARFAESI, and massive write-offs were taken on unrecoverable supplier advances and inventory.
Why it mattersThe sale of factory land, building, and machinery strips the company of its core manufacturing capability, severely threatening its status as a going concern.
Revenue from operations (Q2): ₹0.00Net Loss (Q2): ₹1,524.75 lakhsSARFAESI Asset Auction Realization: ₹2,058.30 lakhsAuction proceeds vs Market Cap: ~206%Supplier advances written off (H1): ₹2,426.01 lakhsInventory written off (Q2): ₹1,118.36 lakhs
📅 Short termNegative sentiment will likely persist as financial results confirm severe operational distress, default on loans, and enforcement of security by lenders.
📈 Long termWith the auction of primary operating assets and zero ongoing operational revenue, the company faces existential solvency and going-concern challenges.
⚠ Risk flags
Loss of primary manufacturing assets via bank auction
Default on bank loan covenants and statutory dues
Large-scale write-offs of inventories (₹11.18 cr) and supplier advances (₹24.26 cr)
Severe liquidity shortage and persistent zero operational revenue
👀 What to Watch
Track the company's remaining debt obligations and whether any operational activities can continue following the liquidation of its core plant, machinery, and factory premises by lenders.
Century Ply Q2 Revenue Up 28.5% to ₹1,780 Cr; Confirms Capex Cycle Peaked with Debt Reduction Focus
Century Plyboards reported its highest-ever quarterly consolidated revenue of ₹1,780 crore in Q2, marking a 28.5% YoY increase. Net profit rose 46% YoY to ₹103.6 crore, while EBITDA margin stood at 13.1% (₹232.3 crore). Management indicated that debt has peaked as large capex projects near completion, expecting around ₹900 crore EBITDA this year, with future cash flows primarily allocated to debt reduction.
high confidence
What changedFiling of Q2 earnings transcript revealing peaked debt trajectory, strong revenue growth across divisions, and shift to balance sheet deleveraging.
Why it mattersDemonstrates operating leverage from newly commissioned assets, expanding return ratios (ROCE improved to 16.67%), and indicates lower capital expenditure going forward.
Q2 Consolidated Revenue: ₹1,780 croreQ2 PAT: ₹103.6 crorePlywood Revenue Growth YoY: 28.6%Expected Full Year EBITDA: close to ₹900 crores
📅 Short termPositive sentiment driven by record quarterly top-line, margin expansion, and clear management guidance on peak debt levels.
📈 Long termAs asset sweating replaces heavy capex, stronger free cash flow generation and debt retirement should support higher ROCE and shareholder value.
⚠ Risk flags
Intense competitive pressures in the MDF business impacting realizations
Raw material timber price fluctuations and reliance on imported core veneer
👀 What to Watch
Track capacity ramp-up at Guwahati and Kandla plywood units and monitor quantum of debt reduction from current ₹1,186 crore debt levels over upcoming quarters.
Mayur Uniquoters Posts Q2 FY27 Consol PAT of ₹57.99 Cr, Up 42% YoY; Concall Transcript Released
Mayur Uniquoters submitted its Q2 FY27 earnings conference call transcript, where management reported consolidated revenue of ₹282.95 crore, up 18% YoY, and consolidated PAT of ₹57.99 crore, rising 42% YoY. Total standalone volume was 77.51 lakh meters, with domestic OEM volume expanding 5% YoY and total exports reaching ₹90.46 crore. Management noted soft demand in the US automotive OEM market over the past two quarters, meeting deliveries by clearing local US warehouse inventory rather than fresh exports from India. The company expects full-year auto export revenues to reach approximately ₹300 crore in FY27 compared to ₹280 crore in FY26.
high confidence
What changedSubmission of the formal transcript detailing management commentary and segmental splits for the Q2 FY27 earnings call held on November 05, 2026.
Why it mattersProvides granular clarity on automotive export softness in the US, inventory destocking dynamics at the US warehouse, and the quarterly progress of higher-margin PU leather.
📅 Short termThe strong 42% YoY PAT expansion provides valuation support, though sequential export OEM shipments may remain moderated by US automotive inventory adjustments.
📈 Long termContinued OEM supplier approvals in the US and Europe alongside the planned ramp-up in PU leather operations remain key drivers for sustaining 20%+ operating margins.
⚠ Risk flags
Slowdown in US passenger car demand leading to downward revisions in OEM supply schedules
Client concentration in automotive seating segments
👀 What to Watch
Monitor whether US automotive OEM dispatch rates recover over H2 FY27 and track the ramp-up in quarterly PU segment revenues toward the company's ₹100-125 crore annual target.
Glass Wall Systems Order Book at ₹957 Cr; Targets ₹500+ Cr Inflows in H2 FY27
Glass Wall Systems released its Q2 FY27 earnings call transcript, highlighting an unexecuted order book of ₹957 crore as of September 30, 2026. The company reported H1 revenue growth of 16% YoY to ₹239 crore, maintaining an EBITDA margin of 25.3% (26.9% excluding pass-through freight) and PAT margin of 19.6%. Management reported fresh order bookings of ₹291 crore in H1 and expects to book at least ₹500 crore in H2 FY27 to maintain an 18-24 month execution visibility. While domestic demand across commercial, residential, and luxury fenestration remains strong, international project launches in the US face temporary pauses due to container and shipping cost uncertainties.
high confidence
What changedSubmission of the formal transcript of the Q2 FY27 post-results earnings conference call held on November 4, 2026.
Why it mattersProvides clear visibility into order pipeline (~₹957 crore order book), revenue growth trajectory (16% in H1), margin profile (~25% EBITDA), and international expansion plans into markets like Israel.
Order book (Sep 30, 2026): Rs.957 croresH1 FY27 Revenue: Rs.239 croresH1 FY27 EBITDA margin: 25.3%Targeted H2 FY27 order inflows: Rs.500 croresOrders booked in H1 FY27: Rs.291 crores
📅 Short termNeutral to mildly positive as the transcript confirms steady margin execution and an active bidding pipeline across Grade A developers in India.
📈 Long termSolid multi-year visibility supported by a ~₹957 crore order book and expansion into high-margin luxury fenestration and export markets.
⚠ Risk flags
Export delays and cautious developer launches in the US due to shipping cost and commodity volatility
Working capital normalization back toward historical 45 days
👀 What to Watch
Track order conversion rates in Q3 and Q4 FY27 to verify if the targeted ₹500+ crore inflows materialize, and monitor export demand recovery amidst international freight headwinds.
Surya Roshni Q2FY27 Revenue Rises 33% YoY to ₹2,448 Cr; Steel Order Book at ₹1,200 Cr
Surya Roshni released its Q2 & H1 FY27 investor presentation reporting a 33% YoY growth in consolidated revenue to ₹2,448 crore, while PAT rose 3% YoY to ₹77 crore. Consolidated EBITDA margin contracted to 5.8% compared to 7.6% in Q2FY26 due to input cost pressures, EPR payments, and brand investments. Steel Pipes & Strips delivered record quarterly volumes of 2.67 lakh tonnes (up 23% YoY), backed by an order book of ~₹1,200 crore. Lighting & Consumer Durables revenue rose 17% YoY to ₹507 crore, supported by an order book above ₹200 crore in Professional Lighting.
high confidence
What changedSurya Roshni published its comprehensive Q2 & H1 FY27 investor presentation detailing operational volumes, order books, and balance sheet status.
Why it mattersVolume growth remains strong at 23% in steel pipes, but EBITDA margins experienced compression YoY, reflecting raw material headwinds and promotional spends despite healthy export demand.
Q2FY27 Revenue: ₹2,448 croreQ2FY27 PAT: ₹77 croreSteel segment volume: 2.67 lakh tonnesSteel segment order book: ₹1,200 croreSteel Order Book vs TTM Revenue: ~15.0%
📅 Short termVolume momentum in both Steel and Lighting businesses provides near-term top-line stability, though margin moderation limits bottom-line expansion.
📈 Long termStructural expansion into value-added API pipes (48% volume mix) and export markets, combined with a virtually debt-free balance sheet, supports long-term earnings stability.
⚠ Risk flags
Steel segment EBITDA per ton dropped 18% YoY to ₹4,105
Operating cash flow turned negative at -₹92 crore in H1FY27 due to working capital expansion (₹295 crore outflow)
Raw material volatility and regulatory costs (EPR) impacting operating margins
👀 What to Watch
Track execution of the ~₹1,200 crore steel order book (especially API pipe exports) in H2FY27 and monitor whether steel EBITDA per tonne recovers toward historical levels above ₹5,000.
Spectrum Q2 Standalone Revenue Up 64% YoY to Rs 190.8 Cr; PBT Surges 164% to Rs 29.6 Cr
Spectrum Electrical Industries reported strong standalone financial results for Q2 FY27 (quarter ended September 30, 2026), with revenue from operations rising 64.4% YoY to Rs 190.78 Cr compared to Rs 116.06 Cr in Q2 FY26. Standalone profit before tax climbed 164.5% YoY to Rs 29.64 Cr from Rs 11.21 Cr. In H1 FY27, cash flow statements reflect substantial capex with purchase of fixed assets reaching Rs 110.55 Cr, funded primarily by Rs 275.02 Cr proceeds from share capital issues.
high confidence
What changedBoard approved Q2 and H1 FY27 financial results showing sharp revenue and PBT growth, confirmed nil deviation in preferential issue proceeds, and appointed an independent director to subsidiary Alric Electric.
Why it mattersDemonstrates accelerating revenue scale and profitability expansion, backed by massive capital expenditure (~16% of TTM revenue deployed in fixed assets during H1).
📅 Short termStrong operational momentum and substantial cash balances (Rs 261 Cr) provide liquidity comfort following the equity fundraise.
📈 Long termHeavy capex execution in H1 supports the company's stated strategy to expand manufacturing capacity and target the EV and smart technology sectors.
⚠ Risk flags
High working capital intensity with trade receivables increasing by Rs 34.01 Cr and inventories by Rs 28.15 Cr in H1
Finance costs increased from Rs 2.54 Cr in Q2 FY26 to Rs 5.65 Cr in Q2 FY27
👀 What to Watch
Monitor whether the expanded asset base (Rs 110.55 Cr capex in H1) translates to sustained quarterly top-line execution above Rs 200 Cr, and observe operating margins given elevated raw material consumption.
CFF Fluid Control Approves 51:49 Joint Venture with TKMS ATLAS ELEKTRONIK
CFF Fluid Control Limited has approved entering into a binding Joint Venture Agreement with Germany-based TKMS ATLAS ELEKTRONIK GmbH. The proposed JV entity, named TKMS CFF Defence Systems Private Limited, will be held 51% by CFF Fluid Control and 49% by TKMS. The partnership aims to manufacture, integrate, and provide lifecycle support for anti-submarine warfare systems under the 'Make in India' initiative. Capital commitments and deal values were not disclosed as definitive agreements are yet to be executed.
high confidence
What changedCFF Fluid Control has formally agreed to partner with global naval technology major TKMS ATLAS ELEKTRONIK to form a majority-owned (51%) domestic defense entity.
Why it mattersThe venture significantly expands CFF's addressable market beyond naval spares into sophisticated anti-submarine warfare systems, leveraging TKMS's global proprietary technology under domestic procurement mandates.
CFF Equity Share: 51%TKMS Equity Share: 49%Deal Size: Not Applicable
📅 Short termPositive sentiment driver given the tie-up with a tier-1 global naval defense partner, though immediate financial impact will be limited until capital deployment and contracts begin.
📈 Long termStructurally positions CFF to bid for large-scale Indian Navy anti-submarine warfare programs, enhancing its technology moat and multi-year order inflow visibility.
⚠ Risk flags
Definitive agreements and capital allocation terms are yet to be finalized
Long gestation periods and tender procurement cycles typical of Indian naval defense programs
👀 What to Watch
Track the execution of definitive agreements and subsequent disclosures regarding initial capital outlay, facility location, and order pipeline for anti-submarine warfare systems.
⚠️How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI
⚡ Free FlashFinance Newsletters
AI-powered market intelligence in your inbox — completely free. Pick your topics; max 1 email per topic per day. Unsubscribe anytime.
✅ Everything below is 100% free — no payment, no card, ever.
🎉
You're subscribed!
A welcome email with your topics is on its way. Want it even faster? Join us on Telegram or WhatsApp:
